Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Bioequivalence of Two Different Capsule Types of Dabigatran: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence of Two Different Capsule Types of Dabigatran: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01290757).
- Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03131895).
- Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A): Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B): Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use: primary endpoint results, effect…
- Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1): Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BIOFLOW-VIndependent statistical analysis of Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- BIOGUIDE-XIndependent statistical analysis of Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees: Complete Statistical AnalysisIndependent statistical analysis of Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Biological Signatures, Probiotic Among Those With mTBI and PTSD: Complete Statistical AnalysisIndependent statistical analysis of Biological Signatures, Probiotic Among Those With mTBI and PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02723344).
- Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Biomarker Assessment of Glutamatergic Target Engagement: Complete Statistical AnalysisIndependent statistical analysis of Biomarker Assessment of Glutamatergic Target Engagement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02134951).
- Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI): Complete Statistical AnalysisIndependent statistical analysis of Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00829985).
- Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression: Complete Statistical AnalysisIndependent statistical analysis of Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03363919).
- Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users: Complete Statistical AnalysisIndependent statistical analysis of Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Biomarkers of Intestinal Mucosal Healing in Crohn’s Disease (P08143): Complete Statistical AnalysisIndependent statistical analysis of Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01349920).
- Biomechanical Validation of the Transfer Assessment Instrument (TAI): Complete Statistical AnalysisIndependent statistical analysis of Biomechanical Validation of the Transfer Assessment Instrument (TAI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01183546).
- Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor: Complete Statistical AnalysisIndependent statistical analysis of Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BIPARKIIIndependent statistical analysis of Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Bipolar Ventricular Tachycardia (VT) Study: Complete Statistical AnalysisIndependent statistical analysis of Bipolar Ventricular Tachycardia (VT) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02374476).
- BISCUITIndependent statistical analysis of A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines: primary endpoint results, effect estimate with confidence interval, sample-size…
- bisphenol-AIndependent statistical analysis of Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- BIVALIndependent statistical analysis of Bivalirudin Infusion for Ventricular Infarction Limitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02565147).
- Bivalent Norovirus Vaccine Study: Complete Statistical AnalysisIndependent statistical analysis of Bivalent Norovirus Vaccine Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01168401).
- Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- BK Treatment Study: Complete Statistical AnalysisIndependent statistical analysis of BK Treatment Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01034176).
- BKM120 as Second-line Therapy for Advanced Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of BKM120 as Second-line Therapy for Advanced Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01289041).
- BLASTIndependent statistical analysis of Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval, sample-size…
- BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults: Complete Statistical AnalysisIndependent statistical analysis of BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts: Complete Statistical AnalysisIndependent statistical analysis of Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Blind Child Melatonin Treatment Study: Complete Statistical AnalysisIndependent statistical analysis of Blind Child Melatonin Treatment Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00691444).
- Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BLINKIndependent statistical analysis of Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD…
- BLINKIndependent statistical analysis of Bifocal Lenses In Nearsighted Kids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02255474).
- BLiSSIndependent statistical analysis of Babies Living Safe and Smokefree: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02602288).
- BLISS-76Independent statistical analysis of A Study of Belimumab in Subjects With Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00410384).
- BLOCk-CTIIndependent statistical analysis of Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Blood Flow Restriction Training (BFR) in an Adolescent Population: Complete Statistical AnalysisIndependent statistical analysis of Blood Flow Restriction Training (BFR) in an Adolescent Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04285879).
- Blood Flow Stimulation in the Lower Limbs by Application of Different External Devices: Complete Statistical AnalysisIndependent statistical analysis of Blood Flow Stimulation in the Lower Limbs by Application of Different External Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Blood Lipopolysaccharide (LPS) Rifaximin Study: Complete Statistical AnalysisIndependent statistical analysis of Blood Lipopolysaccharide (LPS) Rifaximin Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02124512).
- Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension: primary endpoint results, effect estimate…
- Blood Sampling Functionality of Extended Dwell Catheters: Complete Statistical AnalysisIndependent statistical analysis of Blood Sampling Functionality of Extended Dwell Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04409418).